{
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2594, 
        2608
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2919, 
        2933
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2940, 
        2963
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2052, 
        2079
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        478, 
        507
      ]
    }
  ], 
  "Microscopic Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1559, 
        1594
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2227, 
        2233
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2300, 
        2306
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2575, 
        2583
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2234, 
        2250
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2307, 
        2323
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2584, 
        2593
      ]
    }
  ], 
  "Relative Location (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2101, 
        2111
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2204, 
        2213
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2276, 
        2286
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2349, 
        2358
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2451, 
        2459
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2552, 
        2561
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2745, 
        2754
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2081, 
        2082
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PATHLAB_LIS|HOSPITAL 11^9311^MOH|PIMS|CCO|20160504125225|A85A9D8A1D8B480AFF287A54FEE0F15AC36DC6DE|ORU^R01|99999999999999999999|P|2.5|||||\nPID|1||^^^^MRN^HOSPITAL 11&9999&MOH~9999999999&DC&ON^^^^JHN||XXXX^XXXX XXXXX^||99999999|M|||999-9999 XXXXXXXX XXXXXX^^XXXXXXXXXXX^XX^X9X9X9^999|||||||||||||||||||N|\nOBR|1||BZ00604084|11529-5^Surgical Pathology Study Report^LN^BX^Biopsy^L|||20160412|||79065^XXXX^XXXXXXXX^XXXXXX XXX-XXXX^^XX.||||||||||||20160426|||F||||||||\n\n\n\n\n\n\n\nPath report.gross description\n\n1.Specimen consists of 2 tan tissue coresnE\\measuring 6 and 11 mm and 1 fragment measuring innE\\total 1 mm in length by less than 1 mm innE\\diameter. Embedded in toto.nE\nE\\2.Specimen consists of 3 tan tissue coresnE\\measuring 8, 8 and 20 mm and 4 fragmentsnE\\measuring in total 5 mm in length by less than 1nE\\mm in diameter. Embedded in toto.nE\nE\\3.Specimen consists of 4 tan tissue coresnE\\measuring 7, 12, 12 and 18 mm and 3 fragmentsnE\\measuring in total 6 mm in length by less than 1nE\\mm in diameter. Embedded in toto.nE\nE\\4.Specimen consists of 3 tan tissue coresnE\\measuring 8, 15 and 26 mm in length by less thannE\\1 mm in diameter and no fragments. Embedded innE\\toto.nE\nE\\5.Specimen consists of 5 tan tissue coresnE\\measuring 5, 5, 5, 10 and 13 mm and 7 fragmentsnE\\measuring in total 10 mm in length by less than 1nE\\mm in diameter. Embedded in toto.nE\nE\\6.Specimen consists of 4 tan tissue coresnE\\measuring 7, 10, 13 and 18 mm and 4 fragmentsnE\\measuring in total 10 mm in length by less than 1nE\\mm in diameter. Embedded in toto.nE\\\n\n\nPath report.microscopic observation\n\nTumour TypenE\\Adenocarcinoma, conventional typenE\nE\\ExtentnE\\# sites involved/total sites  1 / 6nE\\# cores involved/total cores  1 / 12nE\\Overall % tissue involved  1%nE\\% involvement in mostnE\\extensively involved core  20%nE\nE\\GleasonnE\\Overall Gleason Score (1?, worst)7 (3, 4)nE\\Highest Gleason Score (any site)7 (3, 4)nE\\% Gleason patterns 4, 5  30%nE\nE\\OthernE\\Perineural invasion     Not identifiednE\\Periprostatic fat invasion  Not identifiednE\\\n\n\nPath report.final diagnosis\n\n1.BIOPSY, PROSTATE (RIGHT BASE LATERAL)nE\\- FOCAL CHRONIC INFLAMMATION, NEGATIVE FORnE\\MALIGNANCY.nE\nE\\2.BIOPSY, PROSTATE (RIGHT MID LATERAL)nE\\- BENIGN PROSTATIC TISSUE.nE\nE\\3.BIOPSY, PROSTATE (RIGHT APEX LATERAL)nE\\- BENIGN PROSTATIC TISSUE.nE\nE\\4.BIOPSY, PROSTATE (LEFT BASE LATERAL)nE\\- FOCAL CHRONIC INFLAMMATION, NEGATIVE FORnE\\MALIGNANCY.nE\nE\\5.BIOPSY, PROSTATE (LEFT MID LATERAL)nE\\- FOCAL CHRONIC INFLAMMATION, NEGATIVE FORnE\\MALIGNANCY.nE\nE\\6.BIOPSY, PROSTATE (LEFT APEX LATERAL)nE\\- INVASIVE PROSTATIC ADENOCARCINOMA; GLEASONnE\\SCORE 7/10 (PRIMARY 3, SECONDARY 4); 1/2 CORESnE\\INVOLVED; 20% TISSUE INVOLVEMENT.nE\\?see comment?nE\nE\\COMMENT #6nE\nE\\In the Left Apex lateral biopsy, immunostains fornE\\P63 and HMWK are negative in the adenocarcinomanE\\and stain positively in the non-tumorous glandsnE\\and AMACR is positive in the adenocarcinoma.nE\\\n\n\nPath report.relevant Hx\n\nNot providednE\nE\\Not providednE\\\n\n\n"
}